Welcure Drugs & Pharmaceuticals Ltd Financial Statement
*All values are in Rs. Cr
| Particulars | Jun 2025 | Mar 2025 | Dec 2024 |
|---|---|---|---|
| Revenue | 299.91 | 23.12 | 0.88 |
| Operating Expense | 268.77 | 20.58 | 0.79 |
| Net Profit | 23.30 | 2.54 | 0.04 |
| Net Profit Margin | 7.77 | 10.99 | 4.55 |
| Earning Per Share | 2.07 | 0.33 | 0.04 |
| EBIDTA | 31.14 | 2.55 | 0.09 |
| Effective Tax Rate | 25.18 | TBA | 55.56 |
| Particulars | Jun 2025 |
|---|---|
| Revenue | 299.91 |
| Operating Expense | 268.77 |
| Net Profit | 23.30 |
| Net Profit Margin | 7.77 |
| Earning Per Share | 2.07 |
| EBIDTA | 31.14 |
| Effective Tax Rate | 25.18 |
*All values are in Rs. Cr
Standalone
Consolidated
| Particulars | Mar 2025 | Mar 2024 | Mar 2023 |
|---|---|---|---|
| Total Revenue Annual | 24.55 | TBA | TBA |
| Operating Expenses Annual | 23.67 | 0.23 | 0.13 |
| Operating Profit Annual | 2.79 | -0.14 | 0.10 |
| Interest Annual | TBA | TBA | TBA |
| Depreciation | 0.01 | 0.04 | 0.00 |
| Net Profit Annual | 2.17 | -0.17 | 0.10 |
| Tax Annual | 0.61 | TBA | TBA |
| Particulars | Mar 2025 |
|---|---|
| Total Revenue Annual | 24.55 |
| Operating Expenses Annual | 23.67 |
| Operating Profit Annual | 2.79 |
| Interest Annual | TBA |
| Depreciation | 0.01 |
| Net Profit Annual | 2.17 |
| Tax Annual | 0.61 |
*All values are in Rs. Cr
Standalone
Consolidated
| Particulars | Mar 2025 | Mar 2024 | Mar 2023 |
|---|---|---|---|
| Cash Flow at the Beginning | 0.02 | TBA | 0.07 |
| Cash Flow from Operations | -222.03 | -0.13 | 0.11 |
| Cash Flow from Investing | -0.06 | 0.17 | TBA |
| Cash Flow from Financing | 222.20 | -0.02 | -0.17 |
| Cash Flow at the End | 0.13 | 0.02 | TBA |
| Particulars | Mar 2025 |
|---|---|
| Cash Flow at the Beginning | 0.02 |
| Cash Flow from Operations | -222.03 |
| Cash Flow from Investing | -0.06 |
| Cash Flow from Financing | 222.20 |
| Cash Flow at the End | 0.13 |
*All values are in Rs. Cr
Standalone
Consolidated
| Particulars | Mar 2025 | Mar 2024 | Mar 2023 |
|---|---|---|---|
| PBDIT Margin (%) | 11.73 | TBA | TBA |
| PBIT Margin (%) | 11.69 | TBA | TBA |
| PBT Margin (%) | -118.21 | TBA | TBA |
| Net PROFIT Margin (%) | 8.84 | TBA | TBA |
| Return On Networth / Equity (%) | 3.81 | TBA | 0.62 |
| Return On Networth /Employed (%) | 2.42 | TBA | 0.62 |
| Return On Assets (%) | 1.94 | TBA | TBA |
| Total Debt / Equity (X) | 1.19 | TBA | TBA |
| Asset Turnover Ratio (%) | 0.22 | TBA | TBA |
| Particulars | Mar 2025 |
|---|---|
| PBDIT Margin (%) | 11.73 |
| PBIT Margin (%) | 11.69 |
| PBT Margin (%) | -118.21 |
| Net PROFIT Margin (%) | 8.84 |
| Return On Networth / Equity (%) | 3.81 |
| Return On Networth /Employed (%) | 2.42 |
| Return On Assets (%) | 1.94 |
| Total Debt / Equity (X) | 1.19 |
| Asset Turnover Ratio (%) | 0.22 |
*All values are in Rs. Cr
Standalone
Consolidated
| Particulars | Mar 2025 | Mar 2024 | Mar 2023 |
|---|---|---|---|
| Fixed Assets Annual | 0.03 | 0.02 | 0.06 |
| Total Current Assets Annual | 182.14 | 0.03 | 0.01 |
| Non Current Assets Annual | 84.84 | 1.34 | 1.52 |
| Total Shareholders Funds Annual | 102.51 | 1.34 | 1.52 |
| Total Assets Annual | 266.98 | 1.37 | 1.53 |
| Particulars | Mar 2025 |
|---|---|
| Fixed Assets Annual | 0.03 |
| Total Current Assets Annual | 182.14 |
| Non Current Assets Annual | 84.84 |
| Total Shareholders Funds Annual | 102.51 |
| Total Assets Annual | 266.98 |
No Data Availabe
